Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8608-8612

  Kopitz, Charlotte ^a   Anton, Martina ^a   Gansbacher, Bernd ^a   Krüger, Achim ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN B; CYSTATIN C; CYSTEINE; CYSTEINE PROTEINASE INHIBITOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL INTERACTION; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; FIBROSARCOMA; GENE OVEREXPRESSION; GENE TRANSFER; HOST; LIVER METASTASIS; LUNG METASTASIS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; CATHEPSINS; CYSTATINS; CYSTEINE; FIBROSARCOMA; GENE THERAPY; HUMANS; LUNG NEOPLASMS; MICE;

EID: 25444461098     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1572     Document Type: Article

References (23)

1. Turk B, Turk D, Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 2000;1477:98-111.
2. Sloane BF, Yan S, Podgorski I, et al. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin Cancer Biol 2005;15:149-57.
3. Nagai A, Terashima M, Harada T, et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin Chim Acta 2003;329:53-60.
4. Kos J, Werle B, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 2000;15:84-9.
5. Miyake H, Hara I, Eto H. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression. Anticancer Res 2004;24:2573-7.
6. Abrahamson M, Alvarez-Fernandez M, Nathanson CM. Cystatins. Biochem Soc Symp 2003;70:179-99.
7. Sokol JP, Schiemann WP. Cystatin C antagonizes transforming growth factor β signaling in normal and cancer cells. Mol Cancer Res 2004;2:183-95.
8. Shridhar R, Zhang J, Song J, et al. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 2004;23:2206-15.
9. Konduri SD, Yanamandra N, Siddique K, et al. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 2002;21:8705-12.
10. Foghsgaard L, Wissing D, Mauch D, et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor, J Cell Biol 2001;153:999-1010.
11. Jones N, Shenk T. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 1978;13:181-8.
12. Abrahamson M, Dalboge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett 1988;236:14-8.
13. Ruzindana-Umunyana A, Weber JM. Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase. Antiviral Res 2001;51:203-14.
14. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000;81:2573-604.
15. Hitt M, Bett AJ, Addison CL, Prevec L, Graham FL. Techniques for human adenovirus vector construction and characterization. In: Adolph KW, editor. Viral gene techniques. San Diego: Academic Press; 1995. p. 13-30.
16. Schweinitz A, Steinmetzer T, Banke IJ, et al. Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents. J Biol Chem 2004;279:33613-22.
17. Krüger A, Schirrmacher V, Khokha R. The bacterial lacZ gene: an important tool for metastasis research and evaluation of new cancer therapies. Cancer Metastasis Rev 1998-1999;17:285-94.
18. Krol J, Sato S, Rettenberger P, et al. Novel bi- and trifunctional inhibitors of tumor-associated proteolytic systems. Biol Chem 2003;384:1085-96.
19. Arlt M, Kopitz C, Pennington C, et al. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-Cell lymphoma model. Cancer Res 2002;62:5543-50.
20. Zhang J, Shridhar R, Dai Q, et al. Cystatin m: a novel candidate tumor suppressor gene for breast cancer. Cancer Res 2004;64:6957-64.
21. Ervin H, Cox JL. Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression. Cancer Cell Int 2005;5:14.
22. Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej TE. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 2000;46:193-7.
23. Huh CG, Hakansson K, Nathanson CM, et al. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol 1999;52:332-40.